Suppr超能文献

中枢镇痛药曲马多对去甲肾上腺素和多巴胺体外摄取及释放的影响。

Effects of the central analgesic tramadol on the uptake and release of noradrenaline and dopamine in vitro.

作者信息

Driessen B, Reimann W, Giertz H

机构信息

Grünenthal GmbH, Abteilung Pharmakologie, Aachen, Germany.

出版信息

Br J Pharmacol. 1993 Mar;108(3):806-11. doi: 10.1111/j.1476-5381.1993.tb12882.x.

Abstract
  1. The centrally acting analgesic, tramadol, has low affinity for opioid receptors and therefore presumably other mechanisms of analgesic action. Neurotransmitter release and uptake experiments were used to characterize the effects of tramadol on the central noradrenergic and dopaminergic systems. 2. Tramadol inhibited the uptake of [3H]-noradrenaline into purified rat hypothalamic synaptosomes with an IC50 of 2.8 microM; the (-)-enantiomer was about ten times more potent than the (+)-enantiomer. Results with the principal metabolite O-desmethyltramadol were very similar. Inhibition of dopamine uptake into purified rabbit caudate nucleus synaptosomes was very weak with 62% inhibition of 100 microM. 3. Rat occipital cortex slices were preincubated with [3H]-noradrenaline and rabbit caudate nucleus slices with [3H]-dopamine, then superfused and stimulated electrically. Tramadol, 1 and 10 microM, enhanced the stimulation-evoked [3H]-noradrenaline overflow by 25 and 69%, respectively; the (-)-enantiomer was more potent than the racemate or the (+)-enantiomer. Tramadol, 10 microM, had no effect on dopamine release. 4. The effects of tramadol on the stimulation-evoked [3H]-noradrenaline release were abolished when uptake sites were already blocked by a high concentration of cocaine. 5. The metabolite O-desmethyltramadol showed a slight facilitation of the stimulation-evoked noradrenaline release; the effect was more pronounced in the presence of a high concentration of naloxone. In the presence of cocaine, inhibition of the release was observed similar to the effect of morphine but less potent. 6. The results show that tramadol blocks noradrenaline uptake with selectivity as compared to dopamine uptake. The interaction with the noradrenaline transporter is stereoselective. The principal metabolite O-desmethyltramadol shows in addition to noradrenaline uptake inhibition, opioid inhibition of noradrenaline release.
摘要
  1. 中枢性镇痛药曲马多对阿片受体亲和力低,因此推测其镇痛作用存在其他机制。采用神经递质释放和摄取实验来表征曲马多对中枢去甲肾上腺素能和多巴胺能系统的影响。2. 曲马多抑制[3H] - 去甲肾上腺素摄取进入纯化的大鼠下丘脑突触体,IC50为2.8微摩尔;(-) - 对映体的效力约为(+) - 对映体的十倍。主要代谢产物O - 去甲基曲马多的结果非常相似。曲马多对100微摩尔多巴胺摄取进入纯化的兔尾状核突触体的抑制作用非常弱,抑制率为62%。3. 将大鼠枕叶皮质切片用[3H] - 去甲肾上腺素预孵育,兔尾状核切片用[3H] - 多巴胺预孵育,然后进行灌流并电刺激。1微摩尔和10微摩尔的曲马多分别使刺激诱发的[3H] - 去甲肾上腺素溢出增加25%和69%;(-) - 对映体比消旋体或(+) - 对映体更有效。10微摩尔的曲马多对多巴胺释放无影响。4. 当摄取位点已被高浓度可卡因阻断时,曲马多对刺激诱发的[3H] - 去甲肾上腺素释放的影响被消除。5. 代谢产物O - 去甲基曲马多对刺激诱发的去甲肾上腺素释放有轻微促进作用;在高浓度纳洛酮存在下,这种作用更明显。在可卡因存在下,观察到对释放的抑制作用,类似于吗啡的作用,但效力较弱。6. 结果表明,与多巴胺摄取相比,曲马多选择性阻断去甲肾上腺素摄取。与去甲肾上腺素转运体的相互作用具有立体选择性。主要代谢产物O - 去甲基曲马多除抑制去甲肾上腺素摄取外,还具有阿片样物质抑制去甲肾上腺素释放的作用。

相似文献

引用本文的文献

本文引用的文献

5
Augmentation of central and peripheral morphine analgesia by desipramine.
Arch Int Pharmacodyn Ther. 1982 Oct;259(2):222-9.
10
Presynaptic receptors.突触前受体
Annu Rev Pharmacol Toxicol. 1981;21:7-30. doi: 10.1146/annurev.pa.21.040181.000255.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验